Jakob Begun MD PhD
Inflammatory Bowel Disease
Director IBD, Mater Hospital Brisbane Associate Professor, The University of Queensland
Join to View Full Profile
55 Fruit StBalke 4Boston, MA 02114
Phone+1 617-724-6113
Dr. Begun is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Jakob Begun is a gastroenterologist in Briabane, Australia He received his medical degree from Harvard Medical School and has been in practice 10 years. He specializes in inflammatory bowel disease and is experienced in inflammatory bowel disease, autophagy, microbiome, innate immunity, and human genetics.
Education & Training
Mass General Brigham/Massachusetts General HospitalFellowship, Gastroenterology, 2010 - 2013
Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 2007 - 2009
Harvard Medical SchoolClass of 2007
Harvard Medical SchoolPhD, Biological and Biomedical Sciences, 1998 - 2005
Cornell UniversityBS, Biochemistry, 1993 - 1997
Certifications & Licensure
MA State Medical License 2009 - 2016
Awards, Honors, & Recognition
- Medical Scientist Training Program Award 1998, 1999, 2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007
- Merrit Presidential Award 1998
- Churchill Scholarship 1997, 1998
Publications & Presentations
PubMed
- Epidemiology and Treatment Patterns of Fistulizing Crohn's Disease in a Large, Real-World Australasian Cohort.Jack McNamara, William Wilson, Joseph L Pipicella, Simon Ghaly, Jakob Begun
Gastro Hep Advances. 2025-01-01 - Optimizing 5-aminosalicylate for moderate ulcerative colitis: expert recommendations from the Asia-Pacific, Middle East, and Africa Inflammatory Bowel Disease Coalition.Filiz Akyüz, Yoon Kyo An, Jakob Begun, Satimai Aniwan, Huu Hoang Bui
Intestinal Research. 2025-01-01 - 1 citationsVedolizumab and Ustekinumab Levels in Pregnant Women With Inflammatory Bowel Disease and Infants Exposed In Utero.Ralley Prentice, Emma Flanagan, Emily K Wright, Peter R Gibson, Sam Rosella
Clinical Gastroenterology and Hepatology. 2025-01-01
Journal Articles
- Crystallization of PNMT, the adrenaline-synthesizing enzyme, is critically dependent on a high protein concentration.Begun J, McLeish MJ, Caine JM, Palant E, Grunewald GL, Martin JL, Acta Crystallogr D Biol Crystallogr
- Getting the adrenaline going: crystal structure of the adrenaline-synthesizing enzyme PNMT.Martin JL, Begun J, McLeish MJ, Caine JM, Grunewald GL, Structure
- Crystal structure of an Xrcc4-DNA ligase IV complex.Sibanda BL, Critchlow SE, Begun J, Pei XY, Jackson SP, Blundell TL, Nat Struct Biol
- Join now to see all
Press Mentions
XELJANZ® (Tofacitinib Citrate) PBS-Listed for Patients with Moderate-to-Severe Ulcerative ColitisJuly 5th, 2021- Microba Appoints Int Experts to Accelerate Patient Access to Breakthrough TherapiesJune 28th, 2021
Anatara Lifesciences Ltd Formation of Product Development Advisory BoardOctober 23rd, 2018- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
